OnKure Therapeutics (OKUR) Other Accumulated Expenses (2020 - 2026)

OnKure Therapeutics (OKUR) has 6 years of Other Accumulated Expenses data on file, last reported at $390000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 62.93% year-over-year to $390000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390000.0 (down 62.93% YoY) and the FY2025 annual result came in at $323000.0, down 31.28% from the prior year.
• Other Accumulated Expenses grew to $390000.0 in Q1 2026, from $323000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q3 2025 to a low of $323000.0 in Q4 2025.
• A 4-year average of $669428.6 and a median of $470000.0 in 2024 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses climbed 27.03% — and 2026, when it slumped 62.93%.
• Tracing OKUR's Other Accumulated Expenses over 4 years: stood at $370000.0 in 2023, then advanced by 27.03% to $470000.0 in 2024, then tumbled by 31.28% to $323000.0 in 2025, then grew by 20.74% to $390000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $390000.0 (Q1 2026), $323000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.